Homophilic complex formation of MT1‐MMP facilitates proMMP‐2 activation on the cell surface and promotes tumor cell invasion
暂无分享,去创建一个
Hiroshi Sato | N. Ito | Y. Itoh | M. Seiki | N. Suenaga | T. Aoki | H Sato | M Seiki | Y. Maru | Y Maru | T Aoki | Y Itoh | A Takamura | N Ito | N Suenaga | Akiko Takamura
[1] C. López-Otín,et al. Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation , 1996, The Journal of Biological Chemistry.
[2] Jiahua Xu,et al. Rac1 Mediates Type I Collagen-dependent MMP-2 Activation , 2001, The Journal of Biological Chemistry.
[3] J. Schlessinger,et al. Regulation of signal transduction and signal diversity by receptor oligomerization. , 1994, Trends in biochemical sciences.
[4] Y. Okada,et al. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. , 1996, Cancer research.
[5] G. Giannelli,et al. Role of Cell Surface Metalloprotease Mt1-Mmp in Epithelial Cell Migration over Laminin-5 , 2000, The Journal of cell biology.
[6] Y. Itoh,et al. Plasma Membrane-bound Tissue Inhibitor of Metalloproteinases (TIMP)-2 Specifically Inhibits Matrix Metalloproteinase 2 (Gelatinase A) Activated on the Cell Surface* , 1998, The Journal of Biological Chemistry.
[7] W. Stetler-Stevenson,et al. Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3 , 1996, Cell.
[8] Y. Okada,et al. Membrane Type 1 Matrix Metalloproteinase Digests Interstitial Collagens and Other Extracellular Matrix Macromolecules* , 1997, The Journal of Biological Chemistry.
[9] S. Weiss,et al. Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. , 2000, Molecular biology of the cell.
[10] J. Ward,et al. MT1-MMP-Deficient Mice Develop Dwarfism, Osteopenia, Arthritis, and Connective Tissue Disease due to Inadequate Collagen Turnover , 1999, Cell.
[11] C. López-Otín,et al. The helping hand of collagenase-3 (MMP-13): 2.7 A crystal structure of its C-terminal haemopexin-like domain. , 1996, Journal of molecular biology.
[12] Gillian Murphy,et al. The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A , 1998, The Journal of Biological Chemistry.
[13] W. Bode,et al. The C‐terminal (haemopexin‐like) domain structure of human gelatinase A (MMP2): structural implications for its function , 1996, FEBS letters.
[14] Y. Okada,et al. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. , 1995, Cancer research.
[15] M. Shibuya,et al. Flt-1, a receptor for vascular endothelial growth factor, has transforming and morphogenic potentials , 1998, Oncogene.
[16] S. Ho,et al. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.
[17] B. Caterson,et al. Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites. Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan. , 1998, The Biochemical journal.
[18] A. Strongin,et al. Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.
[19] Y. Itoh,et al. Steps Involved in Activation of the Pro-matrix Metalloproteinase 9 (Progelatinase B)-Tissue Inhibitor of Metalloproteinases-1 Complex by 4-Aminophenylmercuric Acetate and Proteinases (*) , 1995, The Journal of Biological Chemistry.
[20] Stephen J. Weiss,et al. Regulation of Cell Invasion and Morphogenesis in a Three-Dimensional Type I Collagen Matrix by Membrane-Type Matrix Metalloproteinases 1, 2, and 3 , 2000, The Journal of cell biology.
[21] Y. Sasaguri,et al. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. , 1992, The Biochemical journal.
[22] C. Overall,et al. Domain Interactions in the Gelatinase A·TIMP-2·MT1-MMP Activation Complex , 2000, The Journal of Biological Chemistry.
[23] A. Ferrando,et al. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors. , 2000, Cancer research.
[24] Motoharu Seiki,et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.
[25] D. Pei. Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage , 1999, Cell Research.
[26] R. W. Rauser,et al. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[27] M. Barbacid,et al. Nerve growth factor mediates signal transduction through trk homodimer receptors , 1992, Neuron.
[28] Y. Itoh,et al. Membrane Type 4 Matrix Metalloproteinase (MT4-MMP, MMP-17) Is a Glycosylphosphatidylinositol-anchored Proteinase* , 1999, The Journal of Biological Chemistry.
[29] M. C. Ovejero,et al. Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts. , 1997, Journal of cell science.
[30] J. Bonnefoy,et al. Cloning of MMP-26. A novel matrilysin-like proteinase. , 2000, European journal of biochemistry.
[31] K. Imai,et al. Matrix Metalloproteinase 7 (Matrilysin) from Human Rectal Carcinoma Cells , 1995, The Journal of Biological Chemistry.
[32] K. Brew,et al. Folding and characterization of the amino‐terminal domain of human tissue inhibitor of metalloproteinases‐1 (TIMP‐1) expressed at high yield in E. coli , 1996, FEBS letters.
[33] M. Seiki,et al. Intermolecular Autolytic Cleavage Can Contribute to the Activation of Progelatinase A by Cell Membranes (*) , 1995, The Journal of Biological Chemistry.
[34] M. d’Ortho,et al. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form. , 1998, Journal of cell science.
[35] G. Butler,et al. The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation , 1996, The Journal of Biological Chemistry.
[36] Y. Itoh,et al. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate. , 1995, The Biochemical journal.
[37] Y. Itoh,et al. MEMBRANE-TYPE MATRIX METALLOPROTEINASES , 2017 .
[38] J. O'Connell,et al. The role of the C-terminal domain in collagenase and stromelysin specificity. , 1992, The Journal of biological chemistry.
[39] A. Eisen,et al. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[40] S. Weiss,et al. Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins , 1998, Cell.
[41] W. Parks,et al. Epilysin, a Novel Human Matrix Metalloproteinase (MMP-28) Expressed in Testis and Keratinocytes and in Response to Injury* , 2001, The Journal of Biological Chemistry.
[42] Y. Masuho,et al. Membrane‐type 6 matrix metalloproteinase (MT6‐MMP, MMP‐25) is the second glycosyl‐phosphatidyl inositol (GPI)‐anchored MMP , 2000, FEBS letters.
[43] Jian Ni,et al. Identification and Characterization of Human Endometase (Matrix Metalloproteinase-26) from Endometrial Tumor* , 2000, The Journal of Biological Chemistry.
[44] Y. Okada,et al. Membrane‐type 1 MMP (MMP‐14) cleaves at three sites in the aggrecan interglobular domain , 1998, FEBS letters.
[45] P. Basset,et al. Expression of Matrix Metalloproteinases during Rat Skin Wound Healing: Evidence that Membrane Type-1 Matrix Metalloproteinase Is a Stromal Activator of Pro-Gelatinase A , 1997, The Journal of cell biology.
[46] L. Liotta,et al. Tumor cell interactions with the extracellular matrix during invasion and metastasis. , 1993, Annual review of cell biology.
[47] R. Timpl,et al. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. , 1997, European journal of biochemistry.
[48] J. Keski‐Oja,et al. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. , 1998, The Biochemical journal.
[49] C. López-Otín,et al. The Role of the C-terminal Domain of Human Collagenase-3 (MMP-13) in the Activation of Procollagenase-3, Substrate Specificity, and Tissue Inhibitor of Metalloproteinase Interaction* , 1997, The Journal of Biological Chemistry.
[50] A. Eisen,et al. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. , 1989, The Journal of biological chemistry.
[51] John G. Collard,et al. A role for Rac in Tiaml-induced membrane ruffling and invasion , 1995, Nature.
[52] Y. Okada,et al. TIMP-2 Promotes Activation of Progelatinase A by Membrane-type 1 Matrix Metalloproteinase Immobilized on Agarose Beads* , 1998, The Journal of Biological Chemistry.
[53] Y. Okada,et al. Activation of the precursor of gelatinase A/72 kda type IV collagenase/MMP‐2 in lung carcinomas correlates with the expression of membrane‐type matrix metalloproteinase (MT‐MMP) and with lymph node metastasis , 1995, International journal of cancer.